Tagged with Oral

COVID-19 Oral Antivirals Expected to Generate USD 32.5 Billion in 2022
Interview: Shahbaz Ardalan – Managing Director, Alpex Pharma, Switzerland
Interview: CS Hsu Ph.D. – President, Innopharmax, Taiwan
Interview: Paolo Andreatta – CEO, E-Pharma Trento, Italy
Interview: Amjad Laimoun – General Manager, Abbvie Egypt
Interview: Robin Edwards – Plant Manager, Humacao Site, BMS Puerto Rico
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here